Your email has been successfully added to our mailing list.

×
0 6.32391070639305E-05 0.000379434642382864 0.000809460570416836 0.000505912856510545 0.00107506482008484 0.000569151963574296 0.00309871624612666
Stock impact report

AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
Company Research Source: Yahoo! Finance
for the treatment of adult patients with mismatch repair deficient (dMMR) advanced or recurrent endometrial cancer. The approval for expanded use of Imfinzi was based on data from a prespecified exploratory subgroup analysis by MMR status in the phase III DUO-E study. Data from the study showed that treatment with Imfinzi in combination with carboplatin and paclitaxel (chemotherapy), followed by Imfinzi monotherapy reduced the risk of disease progression or death by 58% in patients with dMMR endometrial cancer compared with chemotherapy alone. Treatment with Imfinzi and chemotherapy was generally well tolerated and manageable with no new safety concerns being observed. The three-arm DUO-E study is also evaluating Imfinzi plus chemotherapy followed by Imfinzi plus Lynparza as maintenance therapy in advanced or recurrent endometrial cancer. The Lynparza plus Imfinzi arm of the study has also met the primary endpoint of progression-free survival (PFS). The study continues to asse Show less Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AZN alerts
Opt-in for
AZN alerts

from News Quantified
Opt-in for
AZN alerts

from News Quantified